Drugs / Wharton's Jelly Allograft
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06361485 | Mar 2024 → Mar 2027 expected | — | R3 Stem Cell | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Wharton's Jelly Allograft | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06361485 ↗ |
| Route | Other | “The participants will receive a series of lumbar injections described in the protocol.” NCT06361485 ↗ |